|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Finn RS: Emerging targeted strategies in
advanced hepatocellular carcinoma. Semin Liver Dis. 33 (Suppl
1):S11–S19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Daher S, Massarwa M, Benson AA and Khoury
T: Current and future treatment of hepatocellular carcinoma: An
updated comprehensive review. J Clin Transl Hepatol. 6:69–78. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei P, Yang J, Zhang D, Cui M and Li L:
lncRNA HAND2-AS1 regulates prostate cancer cell growth through
targeting the miR-106a-5p/RBM24 axis. OncoTargets Ther.
13:4523–4531. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hua WF, Zhong Q, Xia TL, Chen Q, Zhang MY,
Zhou AJ, Tu ZW, Qu C, Li MZ, Xia YF, et al: RBM24 suppresses cancer
progression by upregulating miR-25 to target MALAT1 in
nasopharyngeal carcinoma. Cell Death Dis. 7:e23522016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kiledjian M, Wang X and Liebhaber SA:
Identification of two KH domain proteins in the alpha-globin mRNP
stability complex. EMBO J. 14:4357–4364. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Collier B, Goobar-Larsson L, Sokolowski M
and Schwartz S: Translational inhibition in vitro of human
papillomavirus type 16 L2 mRNA mediated through interaction with
heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1
and 2. J Biol Chem. 273:22648–22656. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krecic AM and Swanson MS: hnRNP complexes:
Composition, structure, and function. Curr Opin Cell Biol.
11:363–371. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wurth L: Versatility of RNA-binding
proteins in cancer. Comp Funct Genomics. 2012:1785252012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang D, Ma Y, Ma Z, Liu S, Sun L, Li J,
Zhao F, Li Y, Zhang J, Li S, et al: Circular RNA SMARCA5 suppressed
non small cell lung cancer progression by regulating miR 670
5p/RBM24 axis. Acta Biochim Biophys Sin (Shanghai). 52:1071–1080.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang Y, Zhang M, Qian Y, Xu E, Zhang J
and Chen X: Rbm24, an RNA-binding protein and a target of p53,
regulates p21 expression via mRNA stability. J Biol Chem.
289:3164–3175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu E, Zhang J, Zhang M, Jiang Y, Cho SJ
and Chen X: RNA-binding protein RBM24 regulates p63 expression via
mRNA stability. Mol Cancer Res. 12:359–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruptier C, De Gaspéris A, Ansieau S,
Granjon A, Tanière P, Lafosse I, Shi H, Petitjean A,
Taranchon-Clermont E, Tribollet V, et al: TP63 P2 promoter
functional analysis identifies β-catenin as a key regulator of
ΔNp63 expression. Oncogene. 30:4656–4665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Massion PP, Taflan PM, Jamshedur Rahman
SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR,
Pietenpol JA, Carbone DP, et al: Significance of p63 amplification
and overexpression in lung cancer development and prognosis. Cancer
Res. 63:7113–7121. 2003.PubMed/NCBI
|
|
15
|
Nekulova M, Holcakova J, Coates P and
Vojtesek B: The role of p63 in cancer, stem cells and cancer stem
cells. Cell Mol Biol Lett. 16:296–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang Y, Chen J, Yu Q, Ji T, Zhang B, Xu
J, Dai Y, Xie Y, Lin H, Liang X, et al: Phosphorylated ERK is a
potential prognostic biomarker for Sorafenib response in
hepatocellular carcinoma. Cancer Med. 6:2787–2795. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chaleshi V, Asadzadeh Aghdaei H, Nourian
M, Iravani S, Jalaeikhoo H, Rajaeinejad M, Khoshdel AR and Naghoosi
H: Association of MALAT1 expression in gastric carcinoma and the
significance of its clinicopathologic features in an Iranian
patient. Gastroenterol Hepatol Bed Bench. 14:108–114.
2021.PubMed/NCBI
|
|
18
|
Seo HR: Roles of tumor microenvironment in
hepatocellular carcinoma. Curr Med Chem. 11:82–93. 2015.
|
|
19
|
Song Y, Kim SH, Kim KM, Choi EK, Kim J and
Seo HR: Activated hepatic stellate cells play pivotal roles in
hepatocellular carcinoma cell chemoresistance and migration in
multicellular tumor spheroids. Sci Rep. 6:367502016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carotenuto P, Fassan M, Pandolfo R, Lampis
A, Vicentini C, Cascione L, Paulus-Hock V, Boulter L, Guest R,
Quagliata L, et al: Wnt signalling modulates
transcribed-ultraconserved regions in hepatobiliary cancers. Gut.
66:1268–1277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oh JJ, Taschereau EO, Koegel AK, Ginther
CL, Rotow JK, Isfahani KZ and Slamon DJ: RBM5/H37 tumor suppressor,
located at the lung cancer hot spot 3p21.3, alters expression of
genes involved in metastasis. Lung Cancer. 70:253–262. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sutherland LC, Wang K and Robinson AG:
RBM5 as a putative tumor suppressor gene for lung cancer. J Thorac
Oncol. 5:294–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mourtada-Maarabouni M, Keen J, Clark J,
Cooper CS and Williams GT: Candidate tumor suppressor
LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle
genes. Exp Cell Res. 312:1745–1752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shu L, Yan W and Chen X: RNPC1, an
RNA-binding protein and a target of the p53 family, is required for
maintaining the stability of the basal and stress-induced p21
transcript. Genes Dev. 20:2961–2972. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drewelus I, Göpfert C, Hippel C, Dickmanns
A, Damianitsch K, Pieler T and Dobbelstein M: p63 antagonizes
Wnt-induced transcription. Cell Cycle. 9:580–587. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Katoh M and Katoh M: WNT signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zucchi I, Astigiano S, Bertalot G, Sanzone
S, Cocola C, Pelucchi P, Bertoli G, Stehling M, Barbieri O,
Albertini A, et al: Distinct populations of tumor-initiating cells
derived from a tumor generated by rat mammary cancer stem cells.
Proc Natl Acad Sci USA. 105:16940–16945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cléry A, Blatter M and Allain FH: RNA
recognition motifs: Boring? Not quite. Curr Opin Struct Biol.
18:290–298. 2008. View Article : Google Scholar
|
|
29
|
Sayan BS, Sayan AE, Yang AL, Aqeilan RI,
Candi E, Cohen GM, Knight RA, Croce CM and Melino G: Cleavage of
the transactivation-inhibitory domain of p63 by caspases enhances
apoptosis. Proc Natl Acad Sci USA. 104:10871–10876. 2007.
View Article : Google Scholar : PubMed/NCBI
|
